Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 64503-64504 [2013-25431]
Download as PDF
<![CDATA[
64503
Federal Register / Vol. 78, No. 209 / Tuesday, October 29, 2013 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
WISEWOMAN Awardees ................................
Screening and Assessment and Lifestyle
Program MDE.
Annual Progress Report .................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25450 Filed 10–28–13; 8:45 am]
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2013–25429 Filed 10–28–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention (CDC)
Cancellation: This notice was
published in the Federal Register on
October 2, 2013, Volume 78, Number
191, page 60876. The meeting
previously scheduled to convene on
October 24, 2013, has been cancelled.
Contact Person for More Information:
Gayle Hickman, Committee
Management Specialist, Office Chief of
Staff, CDC, 1600 Clifton Road NE., Mail
Stop D–14, Atlanta, Georgia 30303,
Telephone: (404) 639–7158, Fax: (404)
639–7212, Email: ghickman@cdc.gov.
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
VerDate Mar<15>2010
18:15 Oct 28, 2013
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:00 a.m.–5:00 p.m.
Eastern Time, November 20, 2013.
Place: Teleconference.
Status: Open to the public, without a
verbal public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number, 1–866–659–
0537 and the passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
21
2
24
21
1
16
probability of causation guidelines that
have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to CDC. NIOSH
implements this responsibility for CDC.
The charter was issued on August 3,
2001, renewed at appropriate intervals,
and will expire on August 3, 2015.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes:
Dose reconstruction program quality
management and assurance activities,
including: Current findings from NIOSH
internal dose reconstruction blind
reviews; and discussion of dose
reconstruction cases under review (set
9, and Portsmouth, Hanford, and Oak
Ridge National Laboratory cases from
sets 10–13).
The agenda is subject to change as
priorities dictate.
E:\FR\FM\29OCN1.SGM
29OCN1
64504
Federal Register / Vol. 78, No. 209 / Tuesday, October 29, 2013 / Notices
Contact Person for More Information:
Theodore Katz, Designated Federal
Official, NIOSH, CDC, 1600 Clifton
Road NE., Mailstop E–20, Atlanta
Georgia 30333, Telephone: (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email: ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25431 Filed 10–28–13; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Safety and Occupational Health Study
Section (SOHSS), National Institute for
Occupational Safety and Health
(NIOSH or Institute)
Cancellation: This notice was
published in the Federal Register on
September 12, 2013, Volume 78,
Number 177, Pages 56235–56236.
Contact Person for More Information:
Price Connor, Ph.D., NIOSH Health
Scientist, CDC, 2400 Executive Parkway,
Mailstop E–20, Atlanta, Georgia 30345,
Telephone: (404)498–2511, Fax:
(404)498–2571.
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
18:15 Oct 28, 2013
Jkt 232001
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25426 Filed 10–28–13; 8:45 am]
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–25430 Filed 10–28–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention (CDC)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Advisory Committee to the Director
(ACD), Centers for Disease Control and
Prevention—Health Disparities
Subcommittee (HDS)
Centers for Disease Control and
Prevention
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Mar<15>2010
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Cancellation: This notice was
published in the Federal Register on
September 18, 2013, Volume 78,
Number 181, page 57391. The meeting
previously scheduled to convene on
October 31, 2013, has been cancelled.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated
Federal Official, Office of the Director,
Division of Cancer Prevention and
Control, CDC, 5770 Buford Hwy NE.,
Mail Stop F–70, Atlanta, Georgia 30341,
Telephone: (770) 488–4518, Fax: (770)
488–4760, Email: tfairley@cdc.gov.
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Notice of Cancellatiion: This notice
was published in the Federal Register
on October 22, 2013, Volume 78,
Number 204, page 62635. The meeting
previously scheduled to convene on
October 28, 2013 has been cancelled.
Contact Person for More Information:
Leandris Liburd, Ph.D., M.P.H., M.A.,
Designated Federal Officer, Health
Disparities Subcommittee, Advisory
Committee to the Director, CDC, 1600
Clifton Road, NE., M/S K–77, Atlanta,
GA 30333; Telephone (770) 488–8200,
Email: LEL1@cdc.gov.
This notice is published less than the
required 15 days prior to the start of the
announced meeting, in accordance with
Section 102–3.150(b) of the GSA Final
Rule (2001) that allows for exceptions to
the meeting notification time
requirement. Section 102–3.150(b) states
the following: ‘‘In exceptional
circumstances, the agency or an
independent Presidential advisory
committee may give less than 15
calendar days’ notice, provided that the
reasons for doing so are included in the
advisory committee meeting notice
published in the Federal Register.’’
In this case, the agency is giving less
than 15 days’ notice due to the recent
furlough status of United States Federal
Government, including the U.S.
Department of Health and Human
Services, Centers for Disease Control
and Prevention, from October 1–16,
2013.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 78, Number 209 (Tuesday, October 29, 2013)]
[Notices]
[Pages 64503-64504]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25431]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 10:00 a.m.-5:00 p.m. Eastern Time, November 20,
2013.
Place: Teleconference.
Status: Open to the public, without a verbal public comment period.
The public is welcome to submit written comments in advance of the
meeting, to the contact person below. Written comments received in
advance of the meeting will be included in the official record of the
meeting. The public is also welcome to listen to the meeting by joining
the teleconference at the USA toll-free, dial-in number, 1-866-659-0537
and the passcode is 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing advice
on the development of probability of causation guidelines that have
been promulgated by the Department of Health and Human Services (HHS)
as a final rule; advice on methods of dose reconstruction, which have
also been promulgated by HHS as a final rule; advice on the scientific
validity and quality of dose estimation and reconstruction efforts
being performed for purposes of the compensation program; and advice on
petitions to add classes of workers to the Special Exposure Cohort
(SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2015.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes: Dose reconstruction program quality management and assurance
activities, including: Current findings from NIOSH internal dose
reconstruction blind reviews; and discussion of dose reconstruction
cases under review (set 9, and Portsmouth, Hanford, and Oak Ridge
National Laboratory cases from sets 10-13).
The agenda is subject to change as priorities dictate.
[[Page 64504]]
Contact Person for More Information: Theodore Katz, Designated
Federal Official, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20,
Atlanta Georgia 30333, Telephone: (513) 533-6800, Toll Free 1 (800)
CDC-INFO, Email: ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-25431 Filed 10-28-13; 8:45 am]
BILLING CODE 4163-18-P
